| Financial Year |
March 31 2023 |
| Monetary Funds |
30,368,420.12 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
54,365,835.96 |
| Advances to Suppliers |
44,811,984.07 |
| Other Receivables |
1,375,463.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
445,583,836.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,992,574.98 |
| Total Current Assets |
599,062,250.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
34,814,236.08 |
| Investment Properties |
116,187.43 |
| Fixed Assetes |
1,956,921,331.83 |
| Under-construction Projects |
4,091,441.97 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
75,691,071.54 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
20,430,400.16 |
| Deferred Income Tax Assets |
2,669,744.37 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,106,464,416.28 |
| Total Assets |
2,705,526,666.68 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
109,642,144.43 |
| Accounts Payable |
194,196,978.55 |
| Accounts Received In Advance |
48,571.44 |
| Employee Compensation Payable |
32,865,245.55 |
| Taxes Payable |
4,911,670.86 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
45,328,359.82 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,994,075.39 |
| Other Current Liabilities |
4,953,664.33 |
| Sub-Total of Current Liabilities |
436,045,820.57 |
| Long-term Loans |
1,562,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,557,500.73 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,605,023,711.50 |
| Total Liabilities |
2,041,069,532.07 |
| Paid-In Capital(Or Share Stock) |
176,904,002.00 |
| Capital Surplus |
400,813,618.04 |
| Surplus Reserve |
7,810,550.11 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
78,928,964.46 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
664,457,134.61 |
| Owner's Equity（Stockholder's Equity） |
664,457,134.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,705,526,666.68 |
